Nearly 10% of U.S. population does not have health insurance (U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion [ODPHP], n.d.a). Healthy People 2030 is a national population and public health initiative endorsed by top U.S. government health agencies, setting health goals for the U.S. healthcare system to improve the overall wellbeing of patients in their communities. This course provides an in-depth and interactive analysis of one of the five Healthy People 2030’s domains of social determinants of health (SDOH), healthcare access and quality, and its impact on patient outcomes.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Bahamas Medical Council (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Georgia Board of Nursing (CEBroker Provider #50-290)
Georgia Composite Medical Board - Physician Assistants (CEBroker Provider #50-290)
Kansas State Board of Nursing (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Louisiana State Board Of Medical Examiners - Midwifery (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
Michigan Board of Nursing (CEBroker Provider #50-290)
Michigan Board of Osteopathic Medicine and Surgery (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
Mississippi Board of Nursing (CEBroker Provider #50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
New Hampshire Medical Society (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
New Mexico Board of Nursing (CEBroker Provider #50-290)
New Mexico Certified Nurse Midwives and Licensed Midwives (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
North Dakota Board of Nursing (CEBroker Provider #50-290)
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Oklahoma Board Of Medical Licensure And Supervision - Medical Doctors (CEBroker Provider #50-290) Physicians will receive 0.50 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)>
Physicians will receive 0.50 AMA PRA category 1 Credits™
Wyoming Board of Nursing (CEBroker Provider #50-290)
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Overview
Meet Jade
SDOH
Healthcare Access and Quality
Revisiting Jade
Key Takeaways
Section 3: Barriers and Negative Outcomes
Overview
Provider Shortages
SDOH
Healthcare Inequities and Disparities
Health Literacy
Revisiting Jade
Key Takeaways
Section 4: Strategic Interventions
Healthy People 2030 Goals
Nurse and Provider Care Strategies
Revisiting Jade
Key Takeaways
Section 5: Conclusion
Course Summary
Course Contributor
References
Shalla is a subject matter expert (SME)/writer for Relias. She completed her BSN and two undergraduate degrees with top honors from the University of Wisconsin-Madison. Shalla earned her dual MSN degrees from Johns Hopkins University with top honors. She also maintains her post-baccalaureate nurse educator certificate (NE-BC). Shalla’s tenure spans over 20 years of cross-functional leadership and direct clinical roles in healthcare, biopharma/biotech, government affairs, managed care/market access, nonprofit patient advocacy, and research. Her subject matter expertise is in rare, orphan, and complex diseases. Her sub-expertise is in immune-mediated diseases (rheumatology and immunology), genetics, neurology, hematology/oncology, several pediatric diseases, population/public health, and larger systemic healthcare affairs. Shalla is a published author with leading rare disease experts and a global speaker. She also sits on scientific, advocacy, and legislative advisory boards. She has led national advocacy and disease awareness campaigns, including speaking before congress, leading to the first-in-class rare disease biologic approval and investigative treatment protocols.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.